These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32319626)

  • 21. Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiency.
    Liu Y; He M; Niu M; Zhao Y; Zhu Y; Li Z; Feng N
    Int J Nanomedicine; 2015; 10():3081-95. PubMed ID: 25960649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
    Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics.
    Kim J; Lee YM; Kang Y; Kim WJ
    ACS Nano; 2014 Sep; 8(9):9358-67. PubMed ID: 25184691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca2+-dependent intracellular drug delivery system developed with "raspberry-type" particles-on-a-particle comprising mesoporous silica core and α-synuclein-coated gold nanoparticles.
    Lee D; Hong JW; Park C; Lee H; Lee JE; Hyeon T; Paik SR
    ACS Nano; 2014 Sep; 8(9):8887-95. PubMed ID: 25166911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. siRNA release from gold nanoparticles by nanosecond pulsed laser irradiation and analysis of the involved temperature increase.
    Rudnitzki F; Feineis S; Rahmanzadeh R; Endl E; Lutz J; Groll J; Hüttmann G
    J Biophotonics; 2018 Sep; 11(9):e201700329. PubMed ID: 29704320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photolabile plasmonic vesicles assembled from amphiphilic gold nanoparticles for remote-controlled traceable drug delivery.
    Song J; Fang Z; Wang C; Zhou J; Duan B; Pu L; Duan H
    Nanoscale; 2013 Jul; 5(13):5816-24. PubMed ID: 23689945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipogels responsive to near-infrared light for the triggered release of therapeutic agents.
    Martín-Saavedra F; Ruiz-Hernández E; Escudero-Duch C; Prieto M; Arruebo M; Sadeghi N; Deckers R; Storm G; Hennink WE; Santamaría J; Vilaboa N
    Acta Biomater; 2017 Oct; 61():54-65. PubMed ID: 28801266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
    Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
    Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy.
    Feng Y; Cheng Y; Chang Y; Jian H; Zheng R; Wu X; Xu K; Wang L; Ma X; Li X; Zhang H
    Biomaterials; 2019 Oct; 217():119327. PubMed ID: 31299626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tumor mRNA-dependent gold nanoparticle-molecular beacon carrier for controlled drug release and intracellular imaging.
    Qiao G; Zhuo L; Gao Y; Yu L; Li N; Tang B
    Chem Commun (Camb); 2011 Jul; 47(26):7458-60. PubMed ID: 21589964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fully glutathione degradable waterborne polyurethane nanocarriers: Preparation, redox-sensitivity, and triggered intracellular drug release.
    Omrani I; Babanejad N; Shendi HK; Nabid MR
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):607-616. PubMed ID: 27770933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
    Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
    Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
    Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
    Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
    Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
    Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.